with the addition of streptomycin instead of pyrazinamide, and vancomycin and ceftriaxone were discontinued. Computed tomography (CT) scan showed a mild ventriculomegaly; obstructive hydrocephaly due to the TBM was suggested based on these findings. Dexamethason and acetazolamide were given to reduce the meningeal inflammation.
Due to the suspicion of immunodeficiency, immunologic laboratory tests were performed. Immunoglubins and complement, anti-tetanus and anti-diphtheria seroprotection titers, and B-and T-cell enumeration were all in normal range.
The phagocytic cell function was tested with a nitrobluetetrazolium (NBT) slide test, which was defective. NBT was repeated and flow cytometric dihydrorhodamine 123 (DHR) assay was also performed, and the results were compatible with the diagnosis of CGD. Then, the patient was treated with interferon-␥ as well as co-trimoxazole and itraconazole as prophylactic antibiotics and antifungals. After five days, symptoms including fever improved, except for headache and vomiting. Due to consistent headache, a ventriculoperitoneal shunting was performed, resulting in dramatically improvement of headache and vomiting. After three days, fever and all of the symptoms improved; the patient was discharged with good condition. Anti-TB drugs were continued for nine months, while the patient was prescribed INF-␥ and prophylactic antifungals and antibiotics.
Patients with CGD are prone to life-threatening bacterial and fungal infections due to a defect in intracellular elimination of microorganisms. NADPH oxidase complex of phagocytic cells is a very important component in the defense against catalase positive bacteria such as Staphylococcus aureus, Serratia marcescens, and Aspergillus spp. However, the susceptibility to mycobacterial infections has always been questioned. Although experimental studies have demonstrated no difference between neutrophils of CGD patients and healthy subjects in destroying M. tuberculosis, recent studies have showed more evidence of the possible role of oxidative burst in host defense against mycobacterial infections. 3 The diagnosis of TBM is challenging, especially in patients with underlying immunodeficiency. In the present case, the CGD diagnosis had an important role in successful treatment, 4 There were some alerting clues for the suspicion of CGD, which should have been noted. History of unknown deaths in the family and consanguinity of parents should alert the physicians for possible primary immunodeficiency, as the results of misdiagnosis can be devastating. 5 Prompt diagnosis of underlying immunodeficiency and appropriate treatments are the key elements that can save immunodeficient patients and avoid irreversible organ damage and death.
